analyst
ZY
NASDAQ · ZYME
Zymeworks Inc.
Healthcare · Biotechnology
$26.44
Down-$0.20 (-0.74%)
Updated Sep 12, 2026, 12:18 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.88B
- P/E ratio
- -0.1
- Dividend yield
- 0.00%
- 52-week range
- $21.52 – $31.34
- Volume
- 585.29K
- Avg. volume
- 1.14M
Price performance
ZYME price history
1M range · 19 trading sessions · Daily adjusted prices
ZYME closed at $26.44 after 19 trading sessions, up 5.23% for the selected period.
- Last close
- $26.44
- Period change
- +5.23%
- Period low
- $25.12
- Period high
- $31.05
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $26.81 | $27.04 | $26.39 | $26.435 | 585.29K |
| Sep 9, 2026 | $27.81 | $28.09 | $27.08 | $27.15 | 396.03K |
| Sep 8, 2026 | $28.93 | $28.93 | $28.07 | $28.11 | 443.27K |
| Sep 4, 2026 | $29.81 | $29.99 | $29.0883 | $29.19 | 476.6K |
| Sep 3, 2026 | $31.34 | $31.34 | $29.59 | $29.90 | 790.94K |
| Sep 2, 2026 | $30.00 | $31.17 | $30.00 | $31.05 | 808.1K |
| Sep 1, 2026 | $29.32 | $29.90 | $29.075 | $29.67 | 483.06K |
| Aug 31, 2026 | $28.06 | $29.70 | $27.81 | $29.41 | 716.49K |
| Aug 28, 2026 | $28.91 | $28.91 | $28.18 | $28.27 | 542.19K |
| Aug 27, 2026 | $29.33 | $29.58 | $28.53 | $29.01 | 625.16K |
| Aug 26, 2026 | $27.56 | $30.62 | $27.48 | $29.305 | 1.22M |
| Aug 25, 2026 | $28.86 | $30.50 | $25.6095 | $27.47 | 2.08M |
| Aug 24, 2026 | $28.68 | $28.83 | $27.01 | $28.77 | 824.55K |
| Aug 21, 2026 | $26.97 | $28.74 | $26.77 | $28.67 | 836.38K |
| Aug 20, 2026 | $27.08 | $27.16 | $26.235 | $26.57 | 498.75K |
| Aug 19, 2026 | $27.12 | $27.8326 | $26.365 | $27.21 | 845.21K |
| Aug 18, 2026 | $25.35 | $26.35 | $25.31 | $26.07 | 650.17K |
| Aug 17, 2026 | $25.01 | $25.80 | $24.94 | $25.31 | 442.4K |
| Aug 14, 2026 | $25.62 | $25.73 | $24.89 | $25.12 | 332.6K |
Latest ZYME news
The latest Smart Investors Daily articles mentioning ZYME.
Stock researchMarket Activity · Insider Trades
Loading stock research…